Concentration and fold changes in nitric

BM	Concentration of NO (μM) ± SEM	Fold change, with respect to
BM	Concentration of NO (μM) ± SEM	Control	TG	TG-F
Control	9.46 ± 1.79
TG24	14.67 ± 3.84	(+) 1.55
TG24F	17.96 ± 1.56		(+) 1.22
TG24MF	11.65 ± 3.16		(-) 1.26	(-) 1.54
TG48	16.57 ± 2.51	(+) 1.75
TG48F	7.66 ± 1.55		(-) 2.16*
TG48MF	7.03 ± 1.88		(-) 2.36	(-) 1.09
TG72	18.49 ± 0.63	(+) 1.95#
TG72F	13.58 ± 2.01		(-) 1.36
TG72MF	15.01 ± 3.96		(-) 1.23	(+) 1.11
TG96	20.05 ± 1.32	(+) 2.12#
TG96F	8.74 ± 1.84		(-) 2.29*
TG96MF	7.81 ± 1.11		(-) 2.57*	(-) 1.12

(#: p<0.05 versus Control; *: p<0.05 versus TG; *: p<0.05 versus TG-F)

Table 7: Concentration and fold changes in nitric oxide produced in bone marrow, assayed by Griess Reagent, at 540 nm. With fisetin, there is a 2.16 fold (p<0.05) decrease after 48 h, a 1.36 fold decrease after 72 h and a 2.29 fold (p<0.05) decrease after 96 h. With MCN+fisetin, there is a 1.26 fold decrease after 24 h, a 2.36 fold decrease after 48 h, a 1.23 fold decrease after 72 h and a 2.57 fold (p<0.05) decrease after 96 h.